poisar

Stocks · News reference

Barclays Maintains Overweight on Strategy, Lowers Price Target to $125

BenzingaAug 3, 2026, 12:26 PMBenzinga Newsdesk

Barclays analyst Nik Cremo maintains Strategy (NASDAQ:MSTR) with a Overweight and lowers the price target from $130 to $125.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 3, 2026, 12:26 PM
Checked
Aug 3, 2026, 12:26 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading